BRCA1 gene therapy
Latest Information Update: 15 Aug 2002
At a glance
- Originator Nonindustrial source
- Class Gene therapies
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Ovarian cancer
Most Recent Events
- 18 Nov 1997 Phase-I clinical trials for Ovarian cancer in USA (IV-infusion)
- 18 Nov 1997 New profile